For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and Attruby represents a significant breakthrough . These innovative therapies stabilize the transthyretin protein, slowing its damaging build-up and reducing the severity of the disease . People are now experiencing improvement